Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation
-
Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024
-
CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates
-
Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting
-
Rush Street Interactive to Participate at the Needham Technology, Media, & Consumer Conference
-
Zscaler to Host Third Quarter Fiscal Year 2024 Earnings Conference Call
-
Westland Express launches API integration to streamline tenant insurance for property managers
-
VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
-
Perma-Fix Reports Financial Results and Provides Business Update for the First Quarter of 2024
-
Cerevance Presents at IAPRD XXIX World Congress on Parkinson’s Disease and Related Disorders
-
AEON Biopharma Provides Update on Development Pipeline
-
Stryker declares a $0.80 per share quarterly dividend
-
NEXGEL to Report First Quarter 2024 Financial Results on May 13th
-
Meet-up in 798: the Global Art Destination Captivates 300,000 visitors with Cultural Extravaganza During May Day Holiday
-
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
-
Terra CO2 Enters Permitting Stage for High-Performance Cement Extender Plant in Texas, Creating a Near-Term Solution for Increased Production and Carbon Reduction
-
MeiraGTx Reports First Quarter 2024 Financial and Operational Results
-
ACELYRIN, INC. Announces Leadership Transition
-
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
-
Fulcrum Therapeutics to Participate in Upcoming May Conferences
-
Xunlei Limited Schedules 2024 Unaudited First Quarter Earnings Release on May 16, 2024
-
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research
-
CareCloud Retains Citizens JMP as its Exclusive Capital Structure Advisor
-
Apnimed Announces Completion of Enrollment in Phase 3 LunAIRo Study of AD109, the Potential First Nighttime Oral Treatment for Obstructive Sleep Apnea
-
Annexon Biosciences to Present at the Bank of America Health Care Conference
-
Treasure Global’s ZCITY Secures US$2Million Marketing Contract through its AI Marketing Engine
-
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
-
Stryker declares a $0.80 per share quarterly dividend
-
Direct Travel Continues Growth Momentum with New Additions to Executive Team
-
Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension
-
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
-
Motiv Completes Delivery of Additional 55 Electric Trucks to Purolator
-
red violet to Present at the B. Riley 24th Annual Institutional Investor Conference
-
Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference
-
PDS Biotech to Participate in Upcoming May 2024 Investor Conferences
-
Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
-
RAPT Therapeutics Reports First Quarter 2024 Financial Results
-
Creative Realities to Restructure Debt Through Revolving Credit Facility
-
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
-
Shoals Technologies Group Expands Leadership Team with Key Appointments in International Business and Investor Relations
-
Rush Street Interactive to Participate at the Needham Technology, Media, & Consumer Conference
-
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
-
ACV to Participate in Upcoming Investor Conferences
-
Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
-
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
-
Binance Labs Incubated UXUY Secures $7M Pre-A Round Fundraising, Surpasses $10 Million Total Funding Milestone
-
Acorn’s Q1’24 EPS Improves to $0.03 vs. ($0.03) Loss Per Share on Continued Growth in Remote Monitoring and Control Hardware and Services Revenue
-
illumin Reports First Quarter 2024 Financial Results
-
Mounting Evidence that use of the Mental Health Collaborative Care Model is Associated with Reductions in Total Healthcare Costs
-
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

